GO:0030620 U2 snRNA binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0030620 (U2 snRNA binding) is a molecular function describing the selective binding of a protein or ribonucleoprotein to U2 small nuclear RNA (U2 snRNA).
• U2 snRNA binding is essential for spliceosome assembly and for positioning the branch-site adenosine during pre-mRNA splicing.
• Core U2 snRNP proteins such as SNRPA1, SNRPB2, SF3B1 and the DDX42/DDX46 helicases directly or indirectly contact U2 snRNA.
• U2 snRNA-binding proteins can also act outside splicing: Npl3p binds U2 snRNA with chaperone-like properties, and nuclear RBPs can be translocated to the cytoplasm during viral infection.
• Dysregulation of U2 snRNP components is linked to cancer, including a prometastatic splicing program driven by SNRPA1-RNA interactions.
• CRISPR knockout, point-mutation, knock-in and overexpression models enable causal testing of U2 snRNA-binding proteins in splicing and disease.
Description
GO:0030620, U2 snRNA binding, is a molecular function in the Gene Ontology that describes the binding of a protein or protein complex to U2 small nuclear RNA (U2 snRNA). U2 snRNA is a highly structured, conserved non-coding RNA that forms the catalytic core of the major spliceosome, where it base-pairs with the pre-mRNA branch site and helps position the adenosine that initiates the first catalytic step of splicing. Proteins that bind U2 snRNA are therefore central to spliceosome assembly and to the fidelity of pre-mRNA processing. The function is not limited to canonical splicing. U2 snRNA-binding proteins can act as RNA chaperones, participate in U2 snRNP assembly and remodeling, and influence transcript-specific splicing programs. Some nuclear RNA-binding proteins with U2 snRNA affinity can also relocalize to the cytoplasm under viral infection, suggesting moonlighting roles. Because U2 snRNA binding is a molecular recognition event, it is studied with biochemical binding assays, structural biology, and functional genomics. For researchers, GO:0030620 provides a precise annotation for proteins that directly contact U2 snRNA. Understanding this function helps explain how mutations in spliceosomal proteins alter splicing, how cancer cells rewire splicing programs, and how viral infection can perturb nuclear RNA-binding protein localization.
U2 snRNA binding At A Glance
| GO ID | GO:0030620 |
|---|---|
| GO term | U2 snRNA binding |
| Ontology | molecular_function |
| Synonym | none listed in QuickGO |
| Major function | Binding to U2 small nuclear RNA (U2 snRNA) |
| Biological context | Spliceosome assembly and pre-mRNA splicing |
| Representative proteins | SNRPA1, SNRPB2, SF3B1, DDX42, DDX46, Npl3p |
| Disease relevance | Cancer splicing programs and viral infection responses |
| Research methods | RNA immunoprecipitation, structural biology, CRISPR models |
What Is GO:0030620?
In the Gene Ontology, GO:0030620 (U2 snRNA binding) is defined as binding to a U2 small nuclear RNA (U2 snRNA). It is a molecular_function term, meaning it describes what a gene product does at the molecular level rather than where it acts or what process it participates in. The term covers direct physical interactions between a protein or ribonucleoprotein and U2 snRNA, including sequence-specific and structure-specific recognition. It does not by itself specify spliceosomal assembly, catalysis, or any particular biological process, although U2 snRNA binding is typically a prerequisite for those downstream events.
Why Is U2 snRNA binding Important in Cell Biology?
U2 snRNA binding is important because it is the molecular recognition step that anchors U2 snRNP to the branch site of pre-mRNA, a prerequisite for the first catalytic step of splicing. Without proper U2 snRNA binding, spliceosome assembly stalls and splicing fidelity decreases, which can alter transcriptomes in cancer and other diseases. The function also matters beyond canonical splicing, as U2 snRNA-binding proteins can act as chaperones and can be relocalized during viral infection.
• Required for U2 snRNP assembly and stable incorporation of U2 snRNA into the spliceosome.
• Enables branch-site recognition and positioning of the adenosine that attacks the 5' splice site.
• Supports fidelity of pre-mRNA splicing, affecting transcript diversity and gene expression.
• Contributes to cancer-associated splicing programs, including prometastatic splicing regulated by SNRPA1.
• Provides a mechanistic explanation for how mutations in spliceosomal proteins alter RNA processing.
• Can be modulated by RNA chaperone activity, as shown for Npl3p binding to U2 snRNA.
• May be relevant to antiviral responses when nuclear RBPs relocalize to the cytoplasm.
• Offers a defined molecular function for functional annotation and CRISPR-based causal testing.
Molecular Mechanism of U2 snRNA binding
Recognition of U2 snRNA stem-loop structures
In simple terms: Proteins grab specific folded parts of U2 snRNA.
U2 snRNA folds into conserved stem-loop structures that are recognized by U2 snRNP proteins. Structural and biochemical studies show that proteins such as SNRPA1 and SNRPB2 contact defined regions of U2 snRNA, and Npl3p binds U2 snRNA in a manner compatible with a chaperone role during splicing. This recognition is the first step that commits U2 snRNA to the spliceosome.
Assembly of the U2 snRNP and SF3B complex
In simple terms: Multiple proteins come together with U2 snRNA to build a working machine.
U2 snRNA binding is coupled to assembly of the U2 small nuclear ribonucleoprotein (U2 snRNP), which includes SF3B components such as SF3B1. The RNA helicases DDX42 and DDX46 participate in human U2 snRNP assembly and remodeling, ensuring that U2 snRNA is properly incorporated. This assembly step is essential for the spliceosome to progress to branch-site recognition.
Branch-site recognition and duplex formation
In simple terms: U2 snRNA pairs with the pre-mRNA to select the branch point.
Once bound by U2 snRNP proteins, U2 snRNA base-pairs with the pre-mRNA branch-site sequence. Structural analysis of the human spliceosome has revealed how the branch-site adenosine is recognized and positioned for catalysis, a process that depends on U2 snRNA binding and its protein partners. This duplex formation is a hallmark of the molecular function annotated as U2 snRNA binding.
Chaperone-like and moonlighting roles
In simple terms: Some U2 snRNA-binding proteins do more than just hold the RNA.
Npl3p binds U2 snRNA with properties compatible with an RNA chaperone, suggesting that U2 snRNA binding can facilitate RNA conformational changes during splicing. In addition, alphavirus infection can trigger cytoplasmic translocation of nuclear RNA-binding proteins with moonlighting antiviral roles, indicating that U2 snRNA-binding proteins may have functions outside the nucleus.
Regulation by helicases and splicing factors
In simple terms: Helicases and other factors control when and how U2 snRNA is bound.
DDX42 and DDX46 are RNA helicases that act during human U2 snRNP assembly, influencing the interaction between U2 snRNA and its protein partners. These regulatory steps ensure that U2 snRNA binding is temporally and spatially controlled, which is critical for splicing fidelity.
Key Genes Involved in GO:0030620 U2 snRNA binding
The following genes encode proteins with documented roles in U2 snRNA binding or in the U2 snRNP complexes that directly contact U2 snRNA.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SNRPA1 | U2 snRNP protein that binds U2 snRNA stem-loop IV | Prometastatic splicing program; cancer models |
| SNRPB2 | U2 snRNP protein involved in U2 snRNA recognition | Core spliceosome assembly studies |
| SF3B1 | U2 snRNP component required for branch-site recognition | Cancer-associated splicing factor |
| DDX42 | RNA helicase involved in human U2 snRNP assembly | Spliceosome assembly mechanisms |
| DDX46 | RNA helicase involved in human U2 snRNP assembly | Spliceosome assembly mechanisms |
| NPL3 (yeast Npl3p) | U2 snRNA-binding protein with chaperone-like activity | RNA recognition and chaperone studies |
| U2 snRNA (RNU2) | Non-coding RNA that base-pairs with branch site | Splicing mechanism and structural studies |
| PRPF8 | Spliceosomal protein associated with U2 snRNP function | Spliceosome structure and disease |
| EFTUD2 | Spliceosomal GTPase linked to U2 snRNP dynamics | Spliceosome assembly and disease |
| SF3A1 | U2 snRNP component aiding branch-site recognition | Splicing mechanism |
| SF3A2 | U2 snRNP component aiding branch-site recognition | Splicing mechanism |
| SF3A3 | U2 snRNP component aiding branch-site recognition | Splicing mechanism |
| SF3B2 | U2 snRNP component in SF3B complex | Spliceosome assembly |
| SF3B3 | U2 snRNP component in SF3B complex | Spliceosome assembly |
| SF3B4 | U2 snRNP component in SF3B complex | Spliceosome assembly |
| SF3B5 | U2 snRNP component in SF3B complex | Spliceosome assembly |
| SF3B6 | U2 snRNP component in SF3B complex | Spliceosome assembly |
How Is U2 snRNA binding Regulated?
U2 snRNA binding is regulated at multiple levels. RNA helicases such as DDX42 and DDX46 control U2 snRNP assembly and remodeling, thereby influencing when U2 snRNA becomes accessible to its protein partners. Chaperone-like proteins such as Npl3p can modulate RNA conformation during binding. In addition, cellular stress or viral infection can alter the localization of nuclear RNA-binding proteins, potentially affecting their availability for U2 snRNA binding. These regulatory layers ensure that U2 snRNA binding is coordinated with spliceosome assembly and splicing catalysis.
U2 snRNA binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SNRPA1 | Prometastatic splicing in cancer | Knockout and overexpression in cancer cell lines |
| SF3B1 | Splicing alterations in cancer | Point-mutation knock-in models |
| SNRPB2 | Spliceosome dysfunction | Knockout in human cell lines |
| DDX42 | U2 snRNP assembly defects | Knockout and rescue models |
| DDX46 | U2 snRNP assembly defects | Knockout and rescue models |
Cancer and prometastatic splicing
U2 snRNA-binding proteins can drive cancer-associated splicing programs. SNRPA1 interactions with structured RNA elements regulate a prometastatic splicing program, linking U2 snRNA binding to tumor progression. Mutations or altered expression of U2 snRNP components such as SF3B1 are also associated with splicing changes in cancer.
Spliceosomopathies and developmental disorders
Because U2 snRNA binding is essential for spliceosome assembly, defects in U2 snRNP proteins can impair pre-mRNA splicing and contribute to spliceosomopathies, a group of disorders caused by spliceosomal dysfunction. Structural and mechanistic studies of the human spliceosome provide a framework for interpreting disease-associated mutations in these proteins.
Viral infection and RNA-binding protein relocalization
Alphavirus infection triggers selective cytoplasmic translocation of nuclear RNA-binding proteins with moonlighting antiviral roles, suggesting that U2 snRNA-binding proteins may be redistributed during infection and contribute to antiviral responses. This highlights a non-canonical dimension of U2 snRNA-binding protein biology.
From U2 snRNA binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a U2 snRNA-binding protein essential for splicing? | CRISPR knockout cell line |
| Does a disease-associated mutation alter U2 snRNA binding? | Point-mutation knock-in |
| Can a tagged protein track U2 snRNP assembly? | Tagged knock-in |
| Does overexpression drive a splicing program? | Overexpression cell model |
| Which RNAs are bound by a candidate protein? | RNA immunoprecipitation |
| Does viral infection change protein localization? | Infection model with imaging |
How to Study the U2 snRNA binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA immunoprecipitation (RIP) | Direct protein-RNA interactions | Detecting U2 snRNA binding |
| Cryo-EM / crystallography | Three-dimensional structure of complexes | Spliceosome and U2 snRNP architecture |
| RNA-seq | Transcriptome-wide splicing changes | Knockout/knockdown effects |
| CRISPR knockout | Loss-of-function phenotypes | Testing essentiality of U2 snRNA-binding proteins |
| Point-mutation knock-in | Effect of specific disease variants | Modeling cancer-associated mutations |
| Tagged knock-in | Protein localization and interactions | Tracking U2 snRNP assembly |
| Overexpression | Gain-of-function effects | Driving splicing programs |
| Imaging | Subcellular localization | Viral infection relocalization |
RNA immunoprecipitation and binding assays
RNA immunoprecipitation (RIP) can detect direct binding of proteins to U2 snRNA and other RNAs. A protocol for Arabidopsis RNA immunoprecipitation demonstrates how endogenous RNA-protein complexes can be captured and analyzed. Similar approaches are used to study U2 snRNA-binding proteins in human cells.
Structural biology of U2 snRNP complexes
Cryo-electron microscopy and crystallography have revealed how U2 snRNA and its protein partners recognize the branch site. Structural analysis of the human spliceosome provides a basis for understanding U2 snRNA binding at atomic resolution. These methods complement biochemical binding studies.
Functional genomics and splicing analysis
RNA sequencing and splicing assays can measure the consequences of perturbing U2 snRNA-binding proteins. Knockout or knockdown of factors such as DDX42 and DDX46 followed by RNA-seq reveals changes in splicing and U2 snRNP assembly. Cancer-focused studies use similar approaches to define prometastatic splicing programs.
Imaging and localization studies
Fluorescence imaging can track the localization of U2 snRNA-binding proteins under different conditions. Alphavirus infection triggers cytoplasmic translocation of nuclear RNA-binding proteins, which can be visualized by imaging. Such studies help distinguish nuclear splicing functions from moonlighting roles.
How CRISPR Can Be Used to Study GO:0030620 U2 snRNA binding
Knockout
CRISPR knockout of genes encoding U2 snRNA-binding proteins can reveal whether they are essential for splicing and cell viability. For example, knocking out DDX42 or DDX46 disrupts U2 snRNP assembly and alters splicing patterns. Knockout models are also used to test the requirement for SNRPA1 in cancer cell splicing programs.
Point Mutation
Point-mutation knock-in can model disease-associated variants in U2 snRNP proteins such as SF3B1. These models help determine whether a specific amino acid change alters U2 snRNA binding or branch-site recognition, as suggested by structural studies of the human spliceosome. Such experiments link genotype to splicing phenotype.
Knock-in
Tagged knock-in of U2 snRNA-binding proteins enables visualization and biochemical purification of native complexes. This approach is useful for tracking U2 snRNP assembly and for confirming direct binding to U2 snRNA in cells. Knock-in of reporter constructs can also monitor splicing changes in real time.
Overexpression
Overexpression of U2 snRNA-binding proteins can drive specific splicing programs. For instance, SNRPA1 interactions with structured RNA elements regulate a prometastatic splicing program, and overexpression models can test whether increased protein levels are sufficient to induce these changes. Overexpression can also be combined with RNA-seq to define downstream targets.
How EDITGENE Supports U2 snRNA binding Research
Researchers studying U2 snRNA binding-related genes often need to determine whether a candidate gene is causally involved in splicing, cancer progression, or antiviral responses. EDITGENE provides CRISPR-based cell models and screening services to test these hypotheses directly, from knockout to precise point mutations and tagged knock-ins.
Contact EDITGENE today to design your custom CRISPR model for U2 snRNA binding research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| ISG20 Knockout HEK293 Cell Line | EDJ-KQ5006 | Human | 3669 | Details Get a Quote |
| COIL Knockout HEK293 Cell Line | EDJ-KQ6179 | Human | 8161 | Details Get a Quote |
| RO60 Knockout HEK293 Cell Line | EDJ-KQ15117 | Human | 6738 | Details Get a Quote |
| COIL Knockout A-549 Cell Line | EDJ-KQ30003 | Human | 8161 | Details Get a Quote |
| COIL Knockout HCT 116 Cell Line | EDJ-KQ30004 | Human | 8161 | Details Get a Quote |
| COIL Knockout HeLa Cell Line | EDC09868 | Human | 8161 | Details Get a Quote |
| ISG20 Knockout A-549 Cell Line | EDJ-KQ27911 | Human | 3669 | Details Get a Quote |
| ISG20 Knockout HCT 116 Cell Line | EDJ-KQ27912 | Human | 3669 | Details Get a Quote |
| ISG20 Knockout HeLa Cell Line | EDJ-KQ27913 | Human | 3669 | Details Get a Quote |
| RO60 Knockout A-549 Cell Line | EDJ-KQ45708 | Human | 6738 | Details Get a Quote |
| RO60 Knockout HCT 116 Cell Line | EDJ-KQ45709 | Human | 6738 | Details Get a Quote |
| RO60 Knockout HeLa Cell Line | EDJ-KQ45710 | Human | 6738 | Details Get a Quote |
Frequently Asked Questions About U2 snRNA binding
What is U2 snRNA binding?
U2 snRNA binding (GO:0030620) is a molecular function describing the binding of a protein or ribonucleoprotein to U2 small nuclear RNA, a key step in spliceosome assembly.
What genes are involved in U2 snRNA binding?
Genes include SNRPA1, SNRPB2, SF3B1, DDX42, DDX46, and NPL3, which encode proteins that contact U2 snRNA or function in the U2 snRNP.
Why is U2 snRNA binding important for splicing?
It anchors U2 snRNP to the pre-mRNA branch site, enabling branch-site recognition and the first catalytic step of splicing.
Which proteins bind U2 snRNA?
SNRPA1 and SNRPB2 are core U2 snRNP proteins that bind U2 snRNA, while SF3B components and helicases such as DDX42 and DDX46 support assembly and remodeling.
How is U2 snRNA binding studied?
Common methods include RNA immunoprecipitation, structural biology such as cryo-EM, and functional genomics with RNA-seq after CRISPR perturbation.
Is U2 snRNA binding linked to cancer?
Yes, SNRPA1 interactions with structured RNA elements regulate a prometastatic splicing program, linking U2 snRNA binding to cancer progression.
Can viruses affect U2 snRNA-binding proteins?
Alphavirus infection triggers cytoplasmic translocation of nuclear RNA-binding proteins with moonlighting antiviral roles, which may include U2 snRNA-binding proteins.
What is the GO ID for U2 snRNA binding?
The Gene Ontology ID is GO:0030620, and the ontology aspect is molecular_function.
What are the synonyms for U2 snRNA binding?
QuickGO lists no synonyms for GO:0030620.
How can CRISPR help study U2 snRNA binding?
CRISPR knockout, point-mutation knock-in, tagged knock-in, and overexpression models allow causal testing of U2 snRNA-binding proteins in splicing and disease.
Conclusion
GO:0030620 (U2 snRNA binding) defines a fundamental molecular recognition event that positions U2 snRNA within the spliceosome and enables branch-site recognition during pre-mRNA splicing. Its importance extends to cancer, spliceosomopathies, and viral infection, where U2 snRNA-binding proteins can drive pathological splicing programs or relocalize to new cellular compartments. CRISPR-based models and functional genomics provide powerful tools to dissect these roles and to test causality for individual genes and variants.
References
- 1. Wilkinson ME et al.. 2020. RNA Splicing by the Spliceosome.. Annu Rev Biochem 89:359-388 PMID: 31794245
- 2. Moursy A et al.. 2023. RNA recognition by Npl3p reveals U2 snRNA-binding compatible with a chaperone role during splicing.. Nat Commun 14(1):7166 PMID: 37935663
- 3. Tholen J et al.. 2022. Structural basis of branch site recognition by the human spliceosome.. Science 375(6576):50-57 PMID: 34822310
- 4. Mattaj IW et al.. 1985. Nuclear segregation of U2 snRNA requires binding of specific snRNP proteins.. Cell 40(1):111-8 PMID: 2578319
- 5. Yang F et al.. 2023. Mechanisms of the RNA helicases DDX42 and DDX46 in human U2 snRNP assembly.. Nat Commun 14(1):897 PMID: 36797247
- 6. Fish L et al.. 2021. A prometastatic splicing program regulated by SNRPA1 interactions with structured RNA elements.. Science 372(6543) PMID: 33986153
- 7. Terzi LC et al.. 2009. Arabidopsis RNA immunoprecipitation.. Plant J 59(1):163-8 PMID: 19419533
- 8. Kamel W et al.. 2024. Alphavirus infection triggers selective cytoplasmic translocation of nuclear RBPs with moonlighting antiviral roles.. Mol Cell 84(24):4896-4911.e7 PMID: 39642884
